HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ping-Hui Tseng Selected Research

Ping-Hui Tseng Research Topics

Disease

9Neoplasms (Cancer)
10/2020 - 02/2004
6Prostatic Neoplasms (Prostate Cancer)
11/2005 - 04/2002
3Inflammation (Inflammations)
07/2015 - 01/2010
3Hepatocellular Carcinoma (Hepatoma)
02/2015 - 07/2014
2Lymphoma (Lymphomas)
07/2014 - 11/2010
2Necrosis
07/2014 - 06/2011
2Ischemia
04/2006 - 04/2002
2Stroke (Strokes)
04/2006 - 04/2002
2Carcinogenesis
11/2005 - 06/2004
1Lung Neoplasms (Lung Cancer)
01/2021
1Pneumonia (Pneumonitis)
01/2017
1Tuberculosis (Tuberculoses)
01/2017
1Porcine Reproductive and Respiratory Syndrome (PRRS)
01/2017
1Liver Neoplasms (Liver Cancer)
07/2014
1Carcinoma (Carcinomatosis)
07/2014
1Leukemia
07/2014
1Sepsis (Septicemia)
07/2014
1B-Cell Leukemia (Leukemia, B Cell)
11/2010
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2010
1Autoimmune Diseases (Autoimmune Disease)
01/2010
1Anthrax
06/2008
1Breast Neoplasms (Breast Cancer)
11/2006
1Vascular Diseases (Vascular Disease)
04/2006
1Brain Ischemia (Cerebral Ischemia)
04/2006
1Glioblastoma (Glioblastoma Multiforme)
11/2005
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2005
1Retinoblastoma (Glioblastoma, Retinal)
12/2004
1Infarction (Infarctions)
04/2002
1Cerebral Infarction
04/2002

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
01/2017 - 04/2002
5Celecoxib (Celebrex)FDA Link
11/2006 - 04/2002
3obatoclaxIBA
02/2015 - 07/2014
3Toll-Like Receptors (Toll-Like Receptor)IBA
07/2014 - 01/2010
3Phosphotransferases (Kinase)IBA
05/2005 - 06/2004
2SC-2001IBA
07/2014 - 07/2014
2CytokinesIBA
07/2014 - 01/2010
2Phosphatidylinositols (Phosphatidylinositol)IBA
11/2006 - 07/2003
2Epoprostenol (Prostacyclin)FDA LinkGeneric
04/2006 - 04/2002
2prostacyclin synthetase (prostacyclin synthase)IBA
04/2006 - 04/2002
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021
1MicroRNAs (MicroRNA)IBA
10/2020
1C-Type Lectins (C-Type Lectin)IBA
01/2017
1Pattern Recognition ReceptorsIBA
01/2017
1Toll-Like Receptor 4IBA
07/2015
1CopperIBA
02/2015
1PyrrolesIBA
02/2015
1indoleIBA
02/2015
1ProdigiosinIBA
02/2015
1Transcription Factors (Transcription Factor)IBA
12/2014
1Biological ProductsIBA
12/2014
1Sorafenib (BAY 43-9006)FDA Link
07/2014
1Tumor Necrosis Factor Receptor-Associated Peptides and ProteinsIBA
06/2011
1AntigensIBA
11/2010
1B-Cell Activating FactorIBA
11/2010
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2010
1Interferon Type IIBA
01/2010
1Acetylmuramyl-Alanyl-IsoglutamineIBA
06/2008
1Trastuzumab (Herceptin)FDA Link
11/2006
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
11/2006
1OSU 03012IBA
11/2006
1Messenger RNA (mRNA)IBA
04/2006
1Vasodilator Agents (Vasodilators)IBA
04/2006
1Antineoplastic Agents (Antineoplastics)IBA
11/2005
1Histone Deacetylases (Histone Deacetylase)IBA
11/2005
1Histones (Histone)IBA
11/2005
1Protein Phosphatase 1IBA
11/2005
1Histone Deacetylase InhibitorsIBA
11/2005
1Tyrosine (L-Tyrosine)FDA Link
05/2005
1Imatinib Mesylate (Gleevec)FDA Link
05/2005
1Cyclin-Dependent Kinases (cdk Proteins)IBA
12/2004
13-Phosphoinositide-Dependent Protein KinasesIBA
02/2004
1Serum-Free Culture MediaIBA
07/2003
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
07/2003
1Cyclooxygenase 1IBA
04/2002
1EicosanoidsIBA
04/2002
1LeukotrienesIBA
04/2002
1ProstaglandinsIBA
04/2002
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
04/2002
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2002
1AndrogensIBA
04/2002

Therapy/Procedure

2Therapeutics
12/2014 - 06/2004